Why Has the U.S. Pharmaceutical Market Stagnated?

A conversation with Todd D. Clark, President of Value of Insight Consulting (VOI) and the author of pharmahandbook and generichandbook, about the U.S. Rx prescription drug "Utilization Plateau."

The discussion will feature a recent white paper developed as an excerpt from VOI's new edition of the United States Market: pharmahandbook publication, and focuses on why the pharmaceutical market growth in the United States has slowed dramatically and what the pharmaceutical industry can do to avoid the slow-growth trap.

Questions/Topics To Be Discussed

• Please describe what you mean by structural changes in "pharmaceutical utilization"
• What trends do you see in the evolution of the pharmaceutical market?
• Describe pharma utilization patterns over the years
• What advice can you give pharma marketers to better understand prescriber and patient behavior patterns in order to maintain & grow sales of their products in the face of these trends?